Moderna COVID-19 Vaccine Awaits Health Canada Approval

2 min read | December 19, 2020 02:47 AM EST | By Team Kalkine Media

Google News:

Moderna COVID-19 Vaccine Awaits Health Canada Approval

Recent News

GURU (TSX:GURU) Update Tests Confidence In Consumer Growth Story

Stantec’s Ecosystem Project Win Puts Infrastructure Strategy In Focus

TSX Dividend Leaders Retirees May Watch More Closely

TSX Dividend Stocks Show Resilience Across Key Canadian Sectors

Make Kalkine Media
My Trusted Source

Moderna Inc’s COVID-19 vaccine became the second candidate to get emergency use authorization (EUA) from the US Food and Drug Administration (FDA) on Friday, December 18.

Health Canada, the Canadian drug regulator, is yet to authorize Moderna's vaccine. Canada is expected to get about 168,000 injections of Moderna's vaccine, which will be available for rollout across the country by the end of this month. It will be interesting to watch whether Health Canada will approve Moderna shot in the coming week and joins the FDA’s league .

Moderna’s vaccine has an efficacy rate of 94.5 per cent. Nearly 100 million to 125 million vaccine doses will available globally in the first quarter of 2021, said the company.

Reports claimed that the Canadian government is making arrangements to ship Moderna’s vaccine doses across the country, a sign that the Health Canada may soon approve it.

Canada officially kicked off its COVID-19 vaccination campaign on Monday this week, after the first batch of Pfizer-BioNTech vaccine arrived in the country a day ago. The jab was administered to frontline health care workers and elderly people.

@Kalkine Image 2020

The US has already ordered 200 million of doses of Moderna vaccine jab, of which nearly 20 million doses will be delivered by December-end. About 85 million to 100 million doses will be available in the U.S. by the first quarter of 2021. The rollout will start this week among healthcare personnel. Elderly people are next in line to get vaccinated as per U.S. Centers for Disease Control and Prevention experts’ recommendation on December 13. The U.S. government can order an additional 300 million doses, as per its agreement with the drug maker.

The US provided the authorization, a day after the FDA’s panel of external experts endorsed its use. The development comes a week after the agency approved Pfizer Inc-BioNTech’s vaccine candidate.

The vaccine from Pfizer-BioNTech has been injected into the arms of thousands of healthcare employees this week in a huge nationwide vaccination drive. Moderna shots are expected to commence in the coming days for adults 18 years old and above.

Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Incorporated (Kalkine Media), Business Number: 720744275BC0001 and is available for personal and non-commercial use only. The advice given by Kalkine Media through its Content is general information only and it does not take into account the user’s personal investment objectives, financial situation and specific needs. Users should make their own enquiries about any investment and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary. Kalkine Media is not registered as an investment adviser in Canada under either the provincial or territorial Securities Acts. Some of the Content on this website may be sponsored/non-sponsored, as applicable, however, on the date of publication of any such Content, none of the employees and/or associates of Kalkine Media hold positions in any of the stocks covered by Kalkine Media through its Content. Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used in the Content are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used in the Content unless stated otherwise. The images/music that may be used in the Content are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated or was found to be necessary.